Latest antibodies Stories
PhosImmune and PureMHC Working Together On Immunotherapies for Cancer CHARLOTTESVILLE, Va. and AUSTIN, Texas, Oct. 22, 2014 /PRNewswire/ -- PhosImmune Inc.
PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Patent Provides Coverage for Lpath's Anti-S1P Antibody in Europe SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Lpath, Inc.
-- CIAO!(TM) Technology Maximizes Selectivity of Conditionally Active Antibodies -- SAN DIEGO, Oct.
New cutting-edge report “Global Cancer Monoclonal Antibodies Market & Pipeline Insight” worked out by Kuick Research is now available at MarketPublishers.com. London,
SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
Australian researchers say they have cured mesothelioma in lab mice by giving them a combination of three immune system antibodies. Raleigh, NC (PRWEB) October
AACHEN, Germany, ATLANTA and SHANGHAI, September 30, 2014 /PRNewswire/ -- According to the latest Pivotal Scientific Antibody Market Report [http://www.pivotalscientific.com/antibody-market-report/antibody-market-report-6-01-08-2014
SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.
More Images (1 images) »